Lack of trial data may lead to wrong clinical choices
Data access should be mandatory, argue authorsRelated items from OnMedicaDoctors’ leaders consult on ethical use of dataDrug giant agrees to release all Tamiflu trial dataNICE rejects arguments against wider statin useUS doctor says FDA should have withdrawn rosuvastatinTime to rethink 4.5h window for alteplase after stroke
Source: OnMedica Latest News - Category: UK Health Source Type: news
More News: Activase | Cholesterol | Medical Ethics | Oseltamivir | Statin Therapy | Stroke | Tamiflu | UK Health